argenx
Euronext Amsterdam · LEI 7245009C5FZE6G9ODQ71· Fiscal year 2025
Staff cost per employee
Not disclosed
Employees
Not disclosed
Reference: average annual pay in Healthcare & Pharma, Netherlands: $54.6K (Eurostat earn_ses22_26 (SES 2022), 2022 · full-time equivalent, firms with 10+ staff). Official government wage statistics for the whole industry, not this company's pay. Definitions differ by country; see the source.
Quick read
- Revenue grew 89.9% year over year.
- Revenue has grown two years in a row.
- Operating margin was 25.4% in 2025.
- Operating loss of $21.7M in 2024.
Last 3 years
Revenue
Operating income
See the share price on Google Finance ↗
Investor metrics
2025
- Operating margin
- 25.4%
- Net margin
- 31.1%
- ROE
- 17.6%
- Debt-to-equity
- 18.6%
- Equity ratio
- 84.3%